Found 377 with Last Name = 'blomgren' and Initial = 'pa' TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 0.870nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 1nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 1nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 1.40nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 1.74nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 2nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 2nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 2nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 2nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 2.10nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 2.20nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 2.20nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 2.34nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 2.60nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 2.80nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 2.80nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 3nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 3nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 3.30nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 3.40nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 3.40nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 3.40nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 3.60nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 3.80nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 3.90nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 4nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 4nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 4nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 4.20nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 4.20nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 4.70nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 4.90nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 4.90nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 5nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 5nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 5nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 5.20nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 5.20nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 5.30nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 6nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 6.10nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 6.10nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
Affinity DataIC50: 6.20nMAssay Description:Syk activity was measured using KinEASE (Cisbio), a time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay. In this assay, Syk-ca...More data for this Ligand-Target Pair
Affinity DataIC50: 6.20nMAssay Description:Syk activity was measured using KinEASE (Cisbio), a time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay. In this assay, Syk-ca...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 6.20nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
Affinity DataIC50: 6.20nMpH: 7.0 T: 2°CAssay Description:Syk activity was measured using KinEASE (Cisbio), a time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay. In this assay, Syk-ca...More data for this Ligand-Target Pair
Affinity DataIC50: 6.20nMpH: 7.0Assay Description:Syk activity was measured using KinEASE (Cisbio), a time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay. In this assay, Syk-ca...More data for this Ligand-Target Pair
Affinity DataIC50: 6.20nMAssay Description:Syk activity was measured using KinEASE (Cisbio), a time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay. In this assay, Syk-ca...More data for this Ligand-Target Pair
Affinity DataIC50: 6.20nMAssay Description:Syk activity was measured using KinEASE (Cisbio), a time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay. In this assay, Syk-ca...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Gilead Connecticut, Inc.; Genentech, Inc.
US Patent
Affinity DataIC50: 6.35nMpH: 7.5Assay Description:A generalized procedure for a standard biochemical Btk Kinase Assay that can be used to test Formula I compounds. Alternatively, the Lanthascreen ass...More data for this Ligand-Target Pair
